OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-03-31-accounts

REGISTERED COMPANY NUMBER: (England and Wales) REGISTERED CHARITY NUMBER: 1199493

Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

Thalassemia Relief CIO

Lindley Adams Limited Chartered Accountants 28 Prescott Street Halifax West Yorkshire HX1 2LG

Thalassemia Relief CIO

Contents of the Financial Statements for the Year Ended 31 March 2025

Page
Reference and Administrative Details 1
Report of the Trustees 2 to 4
Statement of Financial Activities 5
Balance Sheet 6
Notes to the Financial Statements 7 to 10
Detailed Statement of Financial Activities 11

Thalassemia Relief CIO

Reference and Administrative Details for the Year Ended 31 March 2025

TRUSTEES A Khan Chair Ms S Kousar Mrs R L Khan COMPANY SECRETARY REGISTERED OFFICE 19 Overton Drive Bradford West Yorkshire BD6 3NE REGISTERED COMPANY NUMBER (England and Wales) REGISTERED CHARITY NUMBER 1199493 ACCOUNTANTS Lindley Adams Limited Chartered Accountants 28 Prescott Street Halifax West Yorkshire HX1 2LG BANKERS Unity Trust Bank PO Box 7193 Planetary Road Willenhall WV1 9DG

Page 1

Thalassemia Relief CIO

Report of the Trustees for the Year Ended 31 March 2025

The trustees present their report and financial statements for the period ended 31st March 2025

The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in th UK and Republic of Ireland (FRS 102) (effective 1 January 2019)

OBJECTIVES AND ACTIVITIES

Objectives and aims

The objects of the CIO are the relief of sickness and the preservation of health of those suffering from thalassemia who reside in Pakistan.

Significant activities

During the period the charity has raised money from public donations.

The monies raised have been used to support the charity's objects in Pakistan.

Public benefit

The charity has referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the aims and objectives and in planning the charity's future activities. In particular the trustees consider how planned activities will contribute to the aims and objectives they have set.

Grantmaking

The charity has established its grant making policy to achieve its objects for the public benefit to improve the health of those suffering from thalassemia in Pakistan.

Volunteers

The charity was grateful for the support of 10 volunteers during the period.

ACHIEVEMENTS AND PERFORMANCE

Charitable activities

During the year £14810( 2024 £15100) grants were made for the treatment of individuals suffering from thalassemia in Pakistan.

Fundraising activities

During the period the charity has raised money from the public by street collections, by having collection boxes in shops,hotels etc. and by direct donations.

FINANCIAL REVIEW

Financial position

During the year the charity has raised £24948 (2024 £23011 ) from its fundraising activities. Costs relating to the raising of funds amounted to £4702 ( 2024 £4924) which were covered by trustees,volunteers and sponsors .Donations made amounted to £14810 ( 2024 £15100) and other costs amounted to £1904 ( 2024 £1963). Reserves and free reserves at 31st March 2025 were £3684 ( 2024 £1521).

Principal funding sources

The principal funding sources were collections from the public.

Reserves policy

The trustees wish to establish a level of reserves (that is those funds that are freely available) that is adequate to enable the charity to operate and meet its objectives and enable the charity to continue as a going concern

Going concern

The trustees have considered the position regarding going concern and have looked at forecasts and are satisfied that,despite only having small reserves at the year end, that the charity will have adequate resources to continue to operate for the foreseeable future.In the short term any deficiencies will be made good by the trustees and donations abroad will be restricted unless sufficient funds are available.For these reasons the trustees continue to adopt the going concern basis for preparing these financial statements.

FUTURE PLANS

The trustees intend to continue collecting donations and fundraising in order to support its charitable projects in Pakistan.

Page 2

Thalassemia Relief CIO

Report of the Trustees for the Year Ended 31 March 2025

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The charity is a Charitable Incorporated Organization (CIO) governed according to its constitution dated on 27th June 2022 .The CIO was recognized as a charity on 29th June 2022 and took over the work of the previously unincorporated association at that date.

The Charity's first accounts covered the period from 18th July 2022 to 31st March 2023

The CIO is an independent charity and not part of any "umbrella" body and is registered in England.

In the event of the CIO being wound up, the members have no liability to contribute to its assets and no personal responsibility for settling its debts and liabilities.

Recruitment and appointment of new trustees

There must be a minimum of three charity trustees. There is no maximum number of trustees.

Apart from the first charity trustees, every trustee must be appointed for a term of three years by a resolution passed at a properly convened meeting of the charity trustees.

In selecting individuals for appointment as charity trustees , the charity trustees must have regard to the skills, knowledge and experience needed for the effective administration of the CIO.

Organisational structure

The trustees manage the affairs of the CIO and make all decisions regarding strategic matters, fundraising and all expenditure.

Induction and training of new trustees

New trustees are supplied with a copy of the constitution and the latest Trustees Annual Report and Accounts and information detailing their role as a trustee and their responsibilities.Training sessions will be given to new trustees to familiarize themselves with the charity and their obligations.

Related parties

The only related parties are the trustees and Mr. B Hussain, a volunteer in Pakistan who is the brother in law of Mr. A Khan (trustee) .None of the related parties are remunerated or receive any benefits in kind.

Risk management

The trustees have a duty to identify and review the risks to which the charity is exposed and to establish systems to mitigate those risks and to provide reasonable assurance against fraud and error.

Internal risks are minimised by the implementation of procedures for the authorisation of all transactions and projects and to ensure compliance with legislation.

External risks relate largely to funding as a result of the economic climate resulting in difficulties in the charity supporting its projects. These risks are minimised as the charity will not commit to funding projects unless sufficient resources are in place and will also look to diversify funding as required.

The procedures are periodically reviewed to ensure they still meet the needs of the charity.

COMMENCEMENT OF ACTIVITIES

The charity is a Charitable Incorporated Organization (CIO) governed according to its constitution dated on 27th June 2022 .The CIO was recognized as a charity on 29th June 2022 and took over the work of the previously unincorporated association at that date.

The Charity's first accounts covered the period from 18th July 2022 to 31st March 2023

STATEMENT OF TRUSTEES' RESPONSIBILITIES

The trustees (who are also the directors of Thalassemia Relief CIO for the purposes of company law) are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Page 3

Thalassemia Relief CIO

Report of the Trustees for the Year Ended 31 March 2025

STATEMENT OF TRUSTEES' RESPONSIBILITIES - continued

Company law requires the trustees to prepare financial statements for each financial year. Under that law, the trustees have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law).

Under company law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial statements, the trustees are required to

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the board of trustees on 22 January 2026 and signed on its behalf by:

A Khan - Trustee

Page 4

Thalassemia Relief CIO

Statement of Financial Activities for the Year Ended 31 March 2025

31.3.25 31.3.24
Unrestricted Total
fund funds
Notes £ £
INCOME AND ENDOWMENTS FROM
Donations and legacies 2 24,948 23,011
EXPENDITURE ON
Raising funds 4,702 4,924
Charitable activities
Charitable activities 14,810 15,625
Other 1,904 1,438
Total 21,416 21,987
NET INCOME 3,532 1,024
RECONCILIATION OF FUNDS
Total funds brought forward 152 (872)
TOTAL FUNDS CARRIED FORWARD 3,684 152
CONTINUING OPERATIONS

All income and expenditure has arisen from continuing activities.

The notes form part of these financial statements

Page 5

Thalassemia Relief CIO

Balance Sheet 31 March 2025

31.3.25 31.3.24
Unrestricted Total
fund funds
Notes £ £
CURRENT ASSETS
Cash at bank 5,244 2,112
CREDITORS
Amounts falling due within one year 7 (1,560) (1,960)
NET CURRENT ASSETS 3,684 152
TOTAL ASSETS LESS CURRENT LIABILITIES 3,684 152
NET ASSETS 3,684 152
FUNDS 8
Unrestricted funds 3,684 152
TOTAL FUNDS 3,684 152

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.

The financial statements were approved by the Board of Trustees and authorised for issue on 22 January 2026 and were signed on its behalf by:

A Khan - Trustee

The notes form part of these financial statements

Page 6

Thalassemia Relief CIO

Notes to the Financial Statements for the Year Ended 31 March 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.

Taxation

The charity is exempt from corporation tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. At present the CIO has no restricted funds.

Financial instruments

The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments.Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Going Concern

These accounts have been prepared on the going concern basis.

2.

DONATIONS AND LEGACIES

DONATIONS AND LEGACIES
31.3.25 31.3.24
£ £
Public donations 20,246 18,087
Monies paid by trustees and volunteers for motor expenses 4,076 2,269
Monies paid in by sponsors to cover advertising and boxes 626 2,655
24,948 23,011

continued...

Page 7

Thalassemia Relief CIO

Notes to the Financial Statements - continued for the Year Ended 31 March 2025

3. GRANTS PAYABLE

During the year grants of £14810 (2024 £ 15100) were made for the treatment of individuals suffering from thalassemia in Pakistan.

4. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024.

Trustees' expenses

There were no trustees' expenses paid for the year ended 31 March 2025 nor for the year ended 31 March 2024.

5. STAFF COSTS

There were no staff costs during the current or prior year.

6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricted
fund
£
INCOME AND ENDOWMENTS FROM
Donations and legacies 23,011
EXPENDITURE ON
Raising funds 4,924
Charitable activities
Charitable activities 15,625
Other 1,438
Total 21,987
NET INCOME 1,024
RECONCILIATION OF FUNDS
Total funds brought forward (872)
TOTAL FUNDS CARRIED FORWARD 152

continued...

Page 8

Thalassemia Relief CIO

Notes to the Financial Statements - continued for the Year Ended 31 March 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£ £
Trade creditors - 820
Accrued expenses 1,560 1,140
1,560 1,960
8. MOVEMENT IN FUNDS
Net
movement At
At 1.4.24 in funds 31.3.25
£ £ £
Unrestricted funds
General fund 152 3,532 3,684
TOTAL FUNDS 152 3,532 3,684
Net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 24,948 (21,416) 3,532
TOTAL FUNDS 24,948 (21,416) 3,532
Comparatives for movement in funds
Net
movement At
At 1.4.23 in funds 31.3.24
£ £ £
Unrestricted funds
General fund (872) 1,024 152
TOTAL FUNDS (872) 1,024 152
Comparative net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 23,011 (21,987) 1,024
TOTAL FUNDS 23,011 (21,987) 1,024

continued...

Page 9

Thalassemia Relief CIO

Notes to the Financial Statements - continued for the Year Ended 31 March 2025

8. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

Net
movement At
At 1.4.23 in funds 31.3.25
£ £ £
Unrestricted funds
General fund (872) 4,556 3,684
TOTAL FUNDS (872) 4,556 3,684

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 47,959 (43,403) 4,556
TOTAL FUNDS 47,959 (43,403) 4,556

9. RELATED PARTY DISCLOSURES

The only related party transactions were donations received from the trustees and volunteers to cover motor expenses incurred by the charity. These amounted to ££4076 in 2025 ( £2269 in 2024).

Page 10

Thalassemia Relief CIO

Detailed Statement of Financial Activities for the Year Ended 31 March 2025

31.3.25 31.3.24
£ £
INCOME AND ENDOWMENTS
Donations and legacies
Public donations 20,246 18,087
Monies paid by trustees and volunteers for
motor expenses 4,076 2,269
Monies paid in by sponsors to cover advertising
and boxes 626 2,655
24,948 23,011
Total incoming resources 24,948 23,011
EXPENDITURE
Raising donations and legacies
Advertising - 750
Motor and travel 4,076 2,269
Collection boxes and badges 626 1,905
4,702 4,924
Charitable activities
Sundries - 525
Grants to patients in Pakistan 14,810 15,100
14,810 15,625
Support costs
Finance
Card collection charges 86 -
Bank charges and interest 71 82
Donation transfer costs 336 336
493 418
Governance costs
Accountancy and legal fees 1,411 1,020
Total resources expended 21,416 21,987
Net income 3,532 1,024

This page does not form part of the statutory financial statements

Page 11